VCs See Rebirth in Life Sci
Life-sciences and health investing, long shunned by venture-capital investors, is making a comeback. Several venture firms globally have raised or are raising funds this year in the $200 million to $400 million range dedicated to life sciences, biotech, and medicine...
24 September 2012•4 mins read
